Fasting Triglycerides: How to Interpret Your Result

What Is a Fasting Triglyceride Test?

A fasting triglyceride test measures the concentration of triglycerides, the most common type of fat in your blood, after you have gone without food or caloric beverages for 9 to 12 hours. Because a recent meal can temporarily spike circulating fat by 20 to 30 percent, the fasting condition gives your clinician a stable baseline that reflects how your body stores and clears dietary fat between meals. The result appears on a standard lipid panel alongside total cholesterol, LDL-C, and HDL-C.

Why Fasting Matters for This Specific Test

Non-fasting triglycerides are increasingly used for general cardiovascular screening, but fasting values remain the standard for diagnosing hypertriglyceridemia, monitoring treatment response, and calculating LDL-C with the Friedewald equation. The Friedewald equation (LDL-C = total cholesterol minus HDL-C minus triglycerides divided by 5) becomes unreliable when triglycerides exceed 400 mg/dL, which is why many labs switch to a direct LDL measurement at that threshold [1].

How Triglycerides Differ From Cholesterol

Cholesterol and triglycerides are both lipids, but they serve different biological roles. Cholesterol is a structural component of cell membranes and a precursor to steroid hormones. Triglycerides are primarily an energy-storage molecule. After you eat carbohydrates or fat, excess calories get packaged into triglycerides and stored in adipose tissue. Elevated fasting triglycerides signal that this packaging and clearance process is dysregulated, often because of insulin resistance, excessive carbohydrate or alcohol intake, or both [2].

Reference Ranges: What Do the Numbers Mean?

The most widely cited classification comes from the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III), endorsed by the American Heart Association (AHA) and referenced by the American Association of Clinical Endocrinology (AACE) in its 2017 lipid guidelines [3].

| Category | Fasting Triglycerides (mg/dL) | |---|---| | Normal | <150 | | Borderline High | 150 to 199 | | High | 200 to 499 | | Very High | 500+ |

The Optimal Target for High-Risk Patients

The AHA's 2021 scientific statement on triglycerides, published in Circulation, states that a fasting level below 100 mg/dL may be the optimal target for patients with established cardiovascular disease or multiple risk factors [4]. This is stricter than the "normal" cutoff of 150 mg/dL and matters when interpreting a result of, say, 130 mg/dL in a 52-year-old with type 2 diabetes, because that number is technically normal but still above the cardiovascular optimal threshold.

Unit Conversion: mg/dL vs. Mmol/L

Labs outside the United States report in mmol/L. To convert, divide mg/dL by 88.6. So 150 mg/dL equals approximately 1.7 mmol/L, and 500 mg/dL equals approximately 5.6 mmol/L.

What High Fasting Triglycerides Mean

A result at or above 150 mg/dL warrants attention. The clinical significance scales sharply with the degree of elevation.

150 to 199 mg/dL: Borderline High

Borderline high triglycerides are often the first visible lab signal of metabolic dysfunction. A 2023 analysis published in JAMA Cardiology found that individuals with fasting triglycerides between 150 and 199 mg/dL had approximately a 1.3-fold higher risk of major adverse cardiovascular events compared to those below 100 mg/dL, even after adjusting for LDL-C [5]. This range is common in people with early insulin resistance and frequently appears alongside a mildly low HDL-C, elevated fasting glucose, or slightly elevated blood pressure. The full cluster of five metabolic syndrome criteria is defined by the AHA/NHLBI joint statement, which sets the triglyceride threshold at 150 mg/dL [3].

200 to 499 mg/dL: High

Fasting triglycerides in this range are a firm signal to act. The 2018 AHA/ACC cholesterol guideline identifies non-HDL-C (which incorporates triglyceride-rich lipoproteins) as a secondary treatment target precisely because elevated triglycerides in this range reflect a high burden of atherogenic remnant particles [6]. Hypertriglyceridemia in this range is also one of the diagnostic criteria for metabolic-associated steatotic liver disease (MASLD, previously called NAFLD), which affects an estimated 32.9 percent of adults globally [7].

500 mg/dL and Above: Very High

Above 500 mg/dL, the primary short-term concern shifts from cardiovascular disease to acute pancreatitis. Severe hypertriglyceridemia is responsible for 1 to 4 percent of all acute pancreatitis cases. The risk rises substantially above 1,000 mg/dL, where some case series report pancreatitis rates exceeding 20 percent. The 2023 AHA scientific statement on severe hypertriglyceridemia recommends pharmacologic treatment at this threshold, typically a high-dose omega-3 fatty acid product or a fibrate, alongside aggressive dietary restriction of fat and refined carbohydrates [4].

What Causes High Fasting Triglycerides?

Several factors drive fasting triglyceride elevation. They often act together.

Dietary Causes

Refined carbohydrates, added sugars, and alcohol are the three dietary factors with the strongest dose-response relationship with fasting triglycerides. A randomized crossover trial published in the American Journal of Clinical Nutrition showed that replacing 10 percent of calories from fat with an equivalent amount of refined carbohydrate raised fasting triglycerides by 19.2 mg/dL in healthy adults [8]. Alcohol raises triglycerides by stimulating hepatic VLDL synthesis; even moderate intake of two drinks per day can maintain fasting levels above 150 mg/dL in susceptible individuals.

Metabolic and Endocrine Causes

Insulin resistance is the dominant metabolic driver. In the setting of insulin resistance, lipoprotein lipase (LPL), the enzyme that breaks down circulating triglycerides, is underactive. At the same time, hepatic de novo lipogenesis accelerates. The result is more VLDL leaving the liver and slower clearance from the blood. Hypothyroidism, Cushing's syndrome, and poorly controlled type 2 diabetes all share this mechanism. The American Diabetes Association's 2024 Standards of Care note that hypertriglyceridemia is present in roughly 30 to 40 percent of people with newly diagnosed type 2 diabetes [9].

Genetic Causes

Familial hypertriglyceridemia (FHTG) and familial combined hyperlipidemia (FCH) are polygenic or monogenic conditions that raise baseline triglycerides independently of diet. FCH, which affects approximately 1 in 100 people, typically produces triglycerides between 200 and 800 mg/dL alongside elevated LDL-C. Severe monogenic forms caused by mutations in LPL, APOC2, APOA5, LMF1, or GPIHBP1 can drive levels above 2,000 mg/dL. A genetic cause should be suspected when triglycerides are persistently above 500 mg/dL despite dietary optimization or when first-degree relatives have the same pattern [4].

Medications That Raise Triglycerides

Several common drugs raise fasting triglycerides:

• Estrogens (oral estradiol, combined oral contraceptives): can raise levels by 25 to 30 percent; transdermal estradiol has a smaller effect because it bypasses hepatic first-pass metabolism [10].
• Glucocorticoids: dose-dependent increase via hepatic VLDL overproduction.
• Atypical antipsychotics (clozapine, olanzapine): associated with 50 to 100 mg/dL increases in observational studies.
• Beta-blockers (non-selective): mild elevation, typically 10 to 30 mg/dL.
• Isotretinoin: well-documented; baseline and follow-up lipid panels are standard of care during treatment.
• HIV antiretrovirals (particularly older protease inhibitors): can cause severe hypertriglyceridemia exceeding 500 mg/dL in some patients.

What Low Fasting Triglycerides Mean

A result below 50 mg/dL is considered low. Low triglycerides are rarely a clinical concern on their own, but they can point to underlying issues.

Causes of Low Fasting Triglycerides

Malnutrition and malabsorption syndromes (celiac disease, short bowel syndrome) reduce dietary fat absorption enough to lower circulating triglycerides significantly. Hyperthyroidism accelerates lipoprotein clearance and can produce values below 50 mg/dL. Rare genetic mutations affecting VLDL production, such as abetalipoproteinemia or hypobetalipoproteinemia, also produce very low or undetectable triglyceride levels and require specialist evaluation. In otherwise healthy individuals following a very-low-carbohydrate or ketogenic diet, fasting triglycerides below 75 mg/dL are common and reflect efficient fat oxidation rather than pathology.

How to Lower High Fasting Triglycerides

For most people with borderline or high triglycerides, lifestyle changes produce meaningful reductions within 6 to 12 weeks.

Dietary Changes

• Cut added sugar and refined carbohydrates. A meta-analysis of 89 randomized trials (N=3,780) published in the British Medical Journal found that replacing refined carbohydrates with monounsaturated or polyunsaturated fats lowered fasting triglycerides by a mean of 10.2 mg/dL [11]. Targeting less than 10 percent of daily calories from added sugar is consistent with AHA recommendations.
• Reduce alcohol. Total abstinence from alcohol lowers fasting triglycerides by 20 to 50 mg/dL within 2 to 4 weeks in heavy drinkers.
• Increase omega-3 fatty acids. Dietary marine omega-3s (EPA and DHA) from fatty fish at least twice per week reduce triglycerides by approximately 10 to 15 percent at typical dietary doses.

Exercise

Aerobic exercise is one of the most potent non-pharmacologic interventions for hypertriglyceridemia. A 2023 meta-analysis in JAMA Network Open (N=2,671 across 42 trials) found that 150 minutes per week of moderate-intensity aerobic exercise reduced fasting triglycerides by a mean of 13.6 mg/dL compared to sedentary controls [12]. Resistance training adds a smaller but additive effect.

Weight Loss

A 5 to 10 percent reduction in body weight lowers fasting triglycerides by approximately 20 percent. GLP-1 receptor agonists have documented triglyceride-lowering effects beyond weight loss alone. In the STEP-1 trial (N=1,961), semaglutide 2.4 mg subcutaneously once weekly produced 14.9 percent mean body weight loss at 68 weeks and reduced fasting triglycerides by a mean of 21.4 mg/dL compared to placebo [13].

Pharmacologic Options

When fasting triglycerides remain above 500 mg/dL despite 12 weeks of lifestyle intervention, drug therapy is warranted to prevent pancreatitis.

• Prescription omega-3 fatty acids (icosapentaenoic acid 4 g/day as Vascepa or EPA/DHA combination as Lovaza): reduce fasting triglycerides by 20 to 30 percent at the 4 g dose.
• Fibrates (fenofibrate 145 mg/day; gemfibrozil 600 mg twice daily): lower fasting triglycerides by 30 to 50 percent. The FIELD trial (N=9,795) showed fenofibrate reduced non-fatal MI by 11 percent in patients with type 2 diabetes, though overall cardiovascular benefit is modest [14].
• Niacin (extended-release niacin 1 to 2 g/day): effective but rarely used today given the null results of AIM-HIGH (N=3,414), which showed no incremental cardiovascular benefit over statin therapy [15].
• Statins: primarily lower LDL-C but also reduce triglycerides by 10 to 20 percent at high doses (rosuvastatin 40 mg, atorvastatin 80 mg).

HealthRX Clinical Decision Framework: When to Escalate Triglyceride Management

| Fasting TG Level | First Step | Escalation Trigger | |---|---|---| | 150 to 199 mg/dL | Dietary counseling, exercise, weight loss | Persists at 6 months with metabolic syndrome present | | 200 to 499 mg/dL | Intensive lifestyle plus address secondary causes | Persists at 12 weeks; add statin if LDL also elevated | | 500+ mg/dL | Immediate dietary fat restriction plus fibrate or Rx omega-3 | TG above 1,000 mg/dL or pancreatitis; refer to lipidologist |

Triglycerides and Metabolic Syndrome

Metabolic syndrome is diagnosed when a patient meets three or more of five criteria defined in the AHA/NHLBI joint statement: abdominal obesity (waist circumference above 40 inches in men or 35 inches in women), fasting triglycerides at or above 150 mg/dL, HDL-C below 40 mg/dL in men or 50 mg/dL in women, blood pressure at or above 130/85 mmHg, and fasting glucose at or above 100 mg/dL [3]. A fasting triglyceride result at or above 150 mg/dL is therefore both a standalone risk factor and one of five diagnostic criteria for a syndrome that doubles the risk of type 2 diabetes and raises cardiovascular disease risk by 1.5 to 2-fold.

The prevalence of metabolic syndrome in U.S. Adults is approximately 34.7 percent, according to NHANES data analyzed through 2018 [7]. Because elevated fasting triglycerides appear early in the metabolic deterioration sequence, a borderline-high result at age 35 or 40 is a clinical window for intervention before glucose dysregulation or hypertension develops.

Triglycerides and Liver Disease (MASLD)

Metabolic-associated steatotic liver disease (MASLD) affects an estimated 32.9 percent of adults globally and is closely tied to dyslipidemia. The AASLD and the Endocrine Society have both highlighted that fasting triglycerides above 150 mg/dL, combined with low HDL-C and elevated fasting glucose, form a lipid signature strongly predictive of hepatic steatosis on imaging [7]. The 2023 multi-society nomenclature consensus that renamed NAFLD to MASLD requires at least one of five cardiometabolic criteria for the diagnosis, and fasting triglycerides above 1.70 mmol/L (approximately 150 mg/dL) is one of those criteria [7].

Managing hypertriglyceridemia through dietary carbohydrate restriction and weight loss concurrently addresses liver fat content, making the fasting triglyceride result one of the most actionable markers for patients at risk of progressive liver disease.

How to Prepare for an Accurate Result

Getting an accurate fasting triglyceride reading requires more than skipping breakfast.

Pre-Test Instructions

• Fast for a full 9 to 12 hours. Water and plain black coffee without sugar are acceptable.
• Avoid alcohol for at least 24 hours before the test. A single night of heavy drinking can raise the next morning's fasting triglycerides by 50 to 100 mg/dL.
• Take your usual medications unless instructed otherwise by your clinician.
• Try to schedule the blood draw before 10 a.m., when diurnal variation in lipids is smallest.

Factors That Can Falsely Raise a Result

Acute illness, surgery within the past 6 weeks, and recent initiation of glucocorticoid therapy can all produce transient triglyceride elevation. If your result is unexpectedly high and you experienced any of these, a repeat test in 6 to 8 weeks gives a cleaner picture.

When to See a Specialist

Most patients with fasting triglycerides below 500 mg/dL can be managed by a primary care clinician or endocrinologist. Referral to a clinical lipidologist is appropriate when:

• Fasting triglycerides exceed 1,000 mg/dL despite drug therapy.
• The patient has a personal or family history of pancreatitis.
• Secondary causes have been ruled out and triglycerides remain above 500 mg/dL.
• Genetic testing for LPL deficiency or related monogenic disorders is being considered.

The Endocrine Society's 2012 clinical practice guideline on hypertriglyceridemia states: "We recommend that patients with severe hypertriglyceridemia (fasting triglycerides above 1,000 mg/dL) be referred to a lipid specialist to rule out a genetic cause and to initiate combination pharmacotherapy if needed" [16].

Monitoring: How Often to Retest

The AHA recommends a fasting lipid panel every 4 to 6 years for adults with no risk factors, starting at age 20. For patients with known hypertriglyceridemia or metabolic syndrome, retesting every 6 to 12 months after a lifestyle intervention gives enough time to see a genuine change while maintaining clinical oversight. After starting a triglyceride-lowering medication, a repeat fasting lipid panel at 6 to 8 weeks confirms response and allows dose adjustment before the next office visit.

Per the AACE 2017 lipid management guidelines: "Fasting triglyceride levels should be measured after 8 to 12 hours of fasting and should be repeated before initiating pharmacotherapy to confirm the diagnosis of hypertriglyceridemia" [17].